Is a
Patent attributes
Patent Jurisdiction
Patent Number
Date of Patent
June 8, 2021
Patent Application Number
17076772
Date Filed
October 21, 2020
Patent Citations
Patent Citations Received
Patent Primary Examiner
Patent abstract
Disclosed herein are methods of treating or reducing incidence of migraine and/or at least one secondary symptom associated with refractory migraine in a subject having refractory migraine comprising administering to the subject a monoclonal antibody that modulates the CGRP pathway. Compositions for use in the disclosed methods are also provided. Antagonist antibody G1 and antibodies derived from G1 directed to CGRP are also described.
Timeline
No Timeline data yet.
Further Resources
No Further Resources data yet.
